Gregory J. Davis
Keine laufenden Positionen mehr
Profil
Gregory J.
Davis is the founder of FLAG Therapeutics, Inc. Prior to this, he worked as Vice President of Business Development at Flamel Technologies SA and as Vice President of Development at Patheon, Inc. Davis holds a Master's in Business Administration from Kenan-Flagler Business School and an undergraduate degree from The University of North Carolina at Charlotte.
Ehemalige bekannte Positionen von Gregory J. Davis
| Unternehmen | Position | Ende |
|---|---|---|
| PATHEON, INC. | Corporate Officer/Principal | 01.09.2012 |
FLAG Therapeutics, Inc.
 FLAG Therapeutics, Inc. BiotechnologyHealth Technology FLAG Therapeutics, Inc. operates as a oncology company. It develops therapies based on two novel classes of small molecule and water-soluble drugs. The company was founded in 2013 and is headquartered in Raleigh, NC. | Gründer | - |
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Corporate Officer/Principal | - |
Ausbildung von Gregory J. Davis
| Kenan-Flagler Business School | Masters Business Admin |
| The University of North Carolina at Charlotte | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
FLAG Therapeutics, Inc.
FLAG Therapeutics, Inc. BiotechnologyHealth Technology FLAG Therapeutics, Inc. operates as a oncology company. It develops therapies based on two novel classes of small molecule and water-soluble drugs. The company was founded in 2013 and is headquartered in Raleigh, NC. | Health Technology |